Tiotropium low

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 2

Tiotropium Respimat Pharmacokinetic Study in COPD

CompletedNCT01222533

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2010-10-31Updated: 2014-05-16

Phase 3

Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02172807

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2000-12-31Updated: 2014-06-24

Related Papers

Tiotropium Respimat: Comparison of bronchodilator efficacy of 5 and 2.5 µg doses

Pneumologie2015-02-04

The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale.

2013-04-0240 citations